Storia in 3 fonti

Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders

Raccontata da

morningstar.com

biopharmadive.com

benzinga.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

morningstar.comStai leggendo4 g fa

Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders

Kaos Capital demands board reset and cash plan at Capricor after $80M burn in H1 2026 from single-asset bet and excessive G&A overhead. Governance lesson for biotech M&A: pipeline concentration without cash discipline triggers restructuring. Tech managers should assess similar risks in their own biotech partnerships and acquisitions.

originale

benzinga.com4 g fa

Why Is Capricor Therapeutics Stock Falling Friday? - Capricor Therapeutics (NASDAQ:CAPR)

Kaos Capital demands governance reset and cash preservation at Capricor Therapeutics after $80.2M burn in H1 2026 and doubled G&A. Investor pressure for M&A and pipeline diversification reflects skepticism on single-asset valuations; disciplined platforms now biotech market expectation.

Timeline cronologica

giovedì 20 agosto 2026·morningstar.com
Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit
Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit
venerdì 21 agosto 2026·biopharmadive.com
Shareholder pressures Capricor; Lilly dives deeper into vaccines
Kaos Capital wants a “governance reset” to alter the Duchenne cell therapy maker’s strategic course. Elsewhere, Bristol Myers furthered efforts to build an “AI-powered” discovery…

Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders

Why Is Capricor Therapeutics Stock Falling Friday? - Capricor Therapeutics (NASDAQ:CAPR)

Timeline cronologica

Capricor Therapeutics, Inc. (CAPR) Investors: September 28, 2026 Lead Plaintiff Deadline in Class Action Lawsuit

Shareholder pressures Capricor; Lilly dives deeper into vaccines

Shareholder pressures Capricor; Lilly dives deeper into vaccines

Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders

/C O R R E C T I O N — Kessler Topaz Meltzer & Check, LLP/

Why Is Capricor Therapeutics Stock Falling Friday? - Capricor Therapeutics (NASDAQ:CAPR)